ArticleSurgical endoscopy2026
Potential conflict of interest of SAGES annual meeting presentations: can we do better?
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Surgical society committee members disclosure of conflict of interest: show me the money.Surgical endoscopy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundACCME defines ineligible companies as "those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products…". Relationships with ineligible companies may create a potential conflict of interest (pCOI). Disclosure of pCOI is essential for integrity of educational programming and ACCME mandates disclosing these relationships. We investigated significant pCOI (spCOI), defined as total payments > $10,000 over the 2 years prior a meeting. We hypothesize that while most authors disclose pCOI appropriately at SAGES, simple disclosure of pCOI does not fully inform audiences of pCOI at scientific meetings.
methodsPayment information for authors at the 2023 and 2024 SAGES Annual Meeting was extracted from the OpenPayments™ database( https://openpaymentsdata.cms.gov ). Authors not found were searched via Google, LinkedIn, affiliation websites, NPI, and/or state medical board websites. Authors were divided as Disclosed pCOI vs. Not Disclosed pCOI, the latter including those with no mention of COI, stated no relevant COI, or stated no COI.
resultsTotal authors were similar in 2023 and 2024(792 vs. 796). Trainees, non-physicians, and non-US physicians were excluded leaving 296 eligible authors in 2023 and 387 in 2024. The proportion of Disclosed was similar in 2023 and 2024(16% vs. 21%; p = ns). Presence of spCOI was similar in 2023 and 2024(25% vs 24%). Average spCOI payment was greater than $100,000 and not statistically different between groups or by meeting year. Only 51.5% of spCOI were disclosed. The highest paid author received over $868,000 in 2023 and over $1.35 million in 2024.
conclusionsThe majority of authors disclosed their pCOI at SAGES in 2023 and 2024. Undisclosed authors may still have spCOI. Disclosure allows audiences to decide if relationships impact data presented. Disclosing the mere existence of pCOI seems insufficient as the amount of dollars is substantially high for some authors. All presentations should include the dollar amounts for full disclosure of pCOI for future programs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.